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Abstract
Rationale Trace conditioning may provide a behavioural
model suitable to examine the maintenance of ‘on line’ infor-
mation and its underlying neural substrates.
Objectives Experiment la was run to establish trace condition-
ing in a shortened procedure which would be suitable to test
the effects of dopamine (DA) D1 receptor agents administered
by microinjection directly into the brain. Experiment lb exam-
ined the effects of the DA D1 agonist SKF81297 and the DA
D1 antagonist SCH23390 following systemic administration
in pre-trained animals. Experiment 2 went on to test the effects
of systemically administered SKF81297 on the acquisition of
trace conditioning. In experiment 3, SKF81297 was adminis-
tered directly in prelimbic (PL) and infralimbic (IL) sub-
regions of medial prefrontal cortex (mPFC) to compare the
role of different mPFC sub-regions.
Results Whilst treatment with SCH23390 impaired motor
responding and/or motivation, SKF81297 had relatively little
effect in the pre-trained animals tested in experiment 1b. How-
ever, systemic SKF81297 depressed the acquisition function
at the 2-s trace interval in experiment 2. Similarly, in experi-
ment 3, SKF81297 (0.1 μg in 1.0 μl) microinjected into either
PL or IL mPFC impaired appetitive conditioning at the 2-s
trace interval.
Conclusions Impaired t race condi t ioning under
SKF81297 is likely to be mediated in part (but not
exclusively) within the IL and PL mPFC sub-regions.
The finding that trace conditioning was impaired rather
than enhanced under SKF81297 provides further evi-
dence for the inverse U-function which has been sug-
gested to be characteristic of mPFC DA function.
Keywords DopamineD1 . SKF81297 . SCH23390 .Medial
prefrontal cortex . Prelimbic . Infralimbic . Trace
conditioning . Rat
Introduction
Working memory has been defined as the capacity to maintain
‘on line’ transitory information in order to allow comprehen-
sion, thinking and planning (Goldman-Rakic 1996). Thus,
working memory provides a likely mechanism for associative
processes in general, and, in particular, when a time interval
must be bridged (Gilmartin et al. 2014). With respect to un-
derlying brain substrates, deficits in working memory have
been attributed to neuronal loss in medial prefrontal (mPFC)
dopamine (DA) pathways (Arnsten et al. 1994; Cai and
Arnsten 1997; Goldman-Rakic and Brown 1981; Harada
et al. 2002; Robbins and Arnsten 2009). Moreover, there is
electrophysiological evidence for the role of mPFC in the
temporal integration of experimental stimuli presented in se-
quences (Fuster et al. 2000). Consistent with the role of DA as
a modulator of aspects of mPFC function, DA depletion in the
caudate nucleus impaired spatial delayed response task perfor-
mance (Collins et al. 2000). Conversely, at the appropriate
dose, DA D1 receptor agonists can counteract impairments
in working memory, as seen for example in aged monkeys
(Arnsten et al. 1994; Cai and Arnsten 1997). Whilst as an
entity mPFC has been implicated in working memory and
temporal processes, the roles of its specific sub-regions in
mediating temporal aspects of working memory, and in par-
ticular the role of DAwithin specific sub-regions, have yet to
be fully established (Cassaday et al. 2014).
Pavlovian trace conditioning procedures require a subject
to learn an association between a conditioned stimulus (CS,
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e.g. noise) which is separated in time from an unconditioned
stimulus (US, e.g. food) outcome (Pavlov 1927). The ability
to bridge time delays in a trace conditioning procedure allows
animals to nonetheless form associations when potentially
causally related events are separated in time. Thus, trace con-
ditioning has been argued to reflect temporal information pro-
cessing, an aspect of relational learning which represents a key
component of working memory (Sweatt 2004). Consistent
with the suggestion that trace conditioning procedures tap
working memory processes, it is very well established that
conventional hippocampal lesions impair trace conditioning,
and this effect is reproducible in a variety of conditioning
procedures (McEchron et al. 2000; Beylin et al. 2001; Quinn
et al. 2002). Moreover, immunohistochemistry for inducible
transcription factor has shown dissociable patterns of activa-
tion in trace versus delay conditioning in hippocampus
(Weitemier and Ryabinin 2004), and N-methyl-D-aspartate
(NMDA) receptor blockade in the dorsal hippocampus can
impair trace conditioning (depending on the trace interval in
use; Misane et al. 2005). These studies have all used aversive-
ly motivated trace conditioning procedures, but a role for hip-
pocampus in appetitive trace conditioning has also been dem-
onstrated (Chan et al. 2014).
Aspects of working memory, in particular, the maintenance
of information on line, are also dependent on the mPFC
(Goldman-Rakic 1996; Miller et al. 1996; Levy and
Goldman-Rakic 2000; Curtis and D’Esposito 2003). Thus,
the role of mPFC in trace conditioning (as well as other as-
pects of working memory) has also begun to be investigated.
Indeed, both lesion (Kronforst-Collins and Disterhoft 1998;
Weible et al. 2000; McLaughlin et al. 2002; Han et al. 2003)
and electrophysiological (Gilmartin and McEchron 2005;
Vidal-Gonzalez et al. 2006) studies have shown a role for
mPFC in trace conditioning procedures. Specifically, it has
been proposed that the maintenance of attentional resources
and working memory allows bridging of the gap between the
CS and US during trace conditioning and that this bridging is
critically dependent on dorsal mPFC (Gilmartin et al. 2014). A
number of studies have compared across mPFC sub-regions
including prelimbic (PL) and infralimbic (IL) cortices; for
example, evidence for functional differentiation between PL
and IL has come from an electrophysiological study showing
increased PL and decreased IL neuronal activity during trace
conditioning at a 20-s trace interval (Gilmartin and McEchron
2005). Later studies from the same laboratory have provided
further evidence consistent with the hypothesis that there are
‘bridging’ cells in PL (Gilmartin et al. 2014). Additionally,
there is other evidence to suggest that a role for PL is more
readily demonstrated when memory processes are engaged,
for example during retention tests (Oswald et al. 2008, 2010;
Runyan et al. 2004).
Moreover, there is evidence for dopaminergic modulation
of trace conditioning (Nelson et al. 2011; Norman and
Cassaday 2003; Cassaday et al. 2005). The present study used
trace conditioning as a behavioural model in otherwise normal
adult rats in which DA function was manipulated experimen-
tally. Specifically, we examined two different trace intervals in
order to test the effects of DAD1 receptor agents at two levels
of baseline: (1) using a short (2 s) trace interval consistent with
relatively high levels of conditioning which would be suitable
to detect impairment and (2) using a longer (10 s) trace
interval to produce a lower level of conditioning which
would be suitable to detect enhancement (Cassaday
et al. 2005, 2008; Kantini et al. 2004). The aims were
to identify the role of DA D1 receptors in trace condi-
tioning and to identify any functional differentiation be-
tween PL and IL mPFC.
An appetitive trace conditioning procedure was used be-
cause appetitive variants are suitable to examine the course of
acquisition over a relatively high number of conditioning tri-
als, as well as the distribution of anticipatory responding with-
in the trace interval (Cassaday et al. 2005, 2008; Kantini et al.
2004). Testing conditioning over a number of trials and days
in this way requires retention to show improvement (Oswald
et al. 2008, 2010; Runyan et al. 2004). This procedure also
includes in-built measures to distinguish motor and motiva-
tional effects from (changes in) responding reflecting associa-
tive learning. This procedure has previously been conducted
over 10 or 14 days at ten or eight trials per day (Cassaday et al.
2005, 2008; Kantini et al. 2004) which would be unsuitable
for a microinjection study because of the likelihood of me-
chanical damage around the cannula tips after as many as 10–
14 injections. Therefore, experiment 1a was conducted to ex-
amine the course of acquisition over a reduced number of
training days with the number of trials per day increased to
30 delivered within a longer training session (of just over
60 min). Experiment 1b tested the effects of the DA D1 re-
ceptor agonist SKF81297 and the DA D1 receptor antagonist
SCH23390 on the expression of learning (in the same rats
trained up in experiment 1a). Experiment 1b was also done
in order to test for non-specific effects which would be
reflected in responding in the inter-trial interval (ITI) and/or
responding when the US was delivered and indicative of like-
ly motor and motivational effects, respectively. Experiment 2
examined the effect of systemic SKF81297 on acquisition
over 4 days. Experiment 3 went on to test the effects of
SKF81297 delivered by microinjection into PL or IL mPFC,
on acquisition over 4 days as in experiment 2.
Materials and methods
Subjects
On arrival in the laboratory, male Wistar rats (Charles Rivers,
UK) were caged in groups of four in individually ventilated
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cages (IVCs) on a 12:12-h light/dark cycle and given free
access to food and water. They were handled daily for 1 week.
Experiment 1 used 24 experimentally naive rats (at mean
weight 217 g, range 192–240 g) and experiment 2 used 48
rats (at mean weight 378 g, range 337–436 g; drug-naive and
counterbalanced for previous behavioural experience). In ex-
periment 3, 48 rats were used: food was freely available until
they reached their target pre-operative weight (mean 285 g,
range 234–332 g). Rats were weighed daily during the first
two post-operative weeks and every 2–3 days thereafter. One
rat died during surgery due to complications under anaesthet-
ic; there were three confirmed cases of meningitis post-
operatively (these rats were removed from the experiment,
and on veterinary advice, Synulox was subsequently admin-
istered subcutaneously 0.05 ml/kg to the remaining rats as a
prophylactic measure); a further three rats had to be humanely
killed when their cannulae became loose; thus, 41 rats com-
pleted the behavioural procedures. Food was removed 3 days
prior to the start of behavioural procedures, which was
11 days post-operatively in experiment 3, and rats were
exposed to sucrose reward pellets in their home cage
over 2 days following the introduction of food restric-
tion. Thereafter, rats received 5 g per 100-g bodyweight
food ration up to 20 g per day; this ration was adjusted
as necessary to allow for healthy weight gain and to
stabilise weights once these exceeded 400 g. The home
cage ration was additional to the 30 sucrose pellets re-
ceived during conditioning. Water was available ad
libitum. All procedures were carried out in accordance
with the principles of laboratory animal care, specifical-
ly the UK Animals Scientific Procedures Act 1986, Pro-
ject Licence number: PPL 40/3716.
Apparatus
Experimental testing was conducted within a set of four fully
automated ventilated conditioning chambers, adapted for ap-
petitive conditioning. The food magazine (recessed in a side
wall of each of the chambers) was constantly illuminated
whenever food was available. Access to the magazine was
via a magazine flap. Nose pokes were recorded by the break-
ing of the photo beam within the food magazine. The US was
one 45-mg sucrose pellet dispensed into the magazine (For-
mula F, Noyes Precision Food, New Hampshire, UK). Two
experimental stimuli were available as potential predictors of
food delivery. The target stimulus was a mixed frequency
noise (CS), presented via a loudspeaker in the roof of the
chamber, set at 72 dB including background and of 5-s dura-
tion. An experimental background stimulus was provided by
three wall-mounted stimulus lights and the house light flash-
ing on (0.5 s) and off (0.5 s), continuously for the duration of
the conditioning session.
Behavioural procedures
Allocation to conditioning groups (and drug treatments in ex-
periment 1b and experiment 2) was counterbalanced by box.
Since experiment 1a confirmed that acquisition was rapid,
drug treatments were subsequently limited to 2–4 days. On
each day, there were 30 pairings of noise CS and food pre-
sented at a 2- or 10-s trace interval.
Pre-conditioning
There were 2 days of shaping to accustom rats to eating from
the magazine. On the first day, the rats were shaped in pairs;
on the second and subsequent days of pre-conditioning, they
were placed individually in the conditioning chambers. On
each of the first 2 days, rats had access to a pre-load of 15
reward pellets with an additional 15 rewards over 15 min to
familiarise rats with the food deliveries. The tray flap door was
propped open on days 1 and 2 but was closed on subsequent
days, so the rats were then required to nose poke the door open
to collect food. Then followed 2 days of baseline sessions,
during which there were 30 unsignalled rewards over
60 min, delivered on a variable interval around 2 min, to
habituate rats to the sounds produced by food delivery.
Conditioning
Depending on the experimental group, the reward (US) was
delivered 2 or 10 s after CS offset (in the two different trace
groups). Thirty signalled rewards were presented on a variable
interval, with the constraint that the ITI was always at least 1.5
times longer than the inter-stimulus interval (ISI) length.
Throughout acquisition, the background stimulus (flashing
lights) was presented continuously. This continuous presenta-
tion also encompassed the 2- or 10-s ISI, as applicable, which
added to the overall duration of a 60-min session so that con-
ditioning sessions were of either 61- or 65-min total duration.
Magazine activity reflects Pavlovian conditioning. Thus,
the most important dependent variables to assess (effects on)
trace conditioning were the number of nose pokes during the
5-s CS and the number of nose pokes during the 2- or 10-s
trace interval between CS and US (the ISI). This responding
was compared with that seen in the 5 s after the delivery of the
US in acquisition and in the remainder of the session (the ITI,
which excluded responding in the ISI). In order to examine
drug effects on conditioning to the experimental background
stimulus in experiments 2 and 3, extinction tests con-
ducted 48 h after conditioning procedures had been
completed used 30 5-s presentations of the same flash-
ing light stimulus over 60 min. The number of nose
pokes was recorded as above.
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Experiments 1b and 2: systemic injection procedure
Drug doses were based on a previous study run in our labora-
tory (Nelson et al. 2012). Both SKF81297 and SCH23390
(Tocris, UK) were dissolved in saline (0.9 % NaCl) to provide
an injection volume of 1 ml/kg. The final pH was adjusted as
necessary, to approximately 7 using 0.1 M NaOH. In experi-
ments 1b and 2, SKF81297 (0.4 or 0.8 mg/kg) or vehicle was
injected sub-cutaneously (s.c.) 15 min before conditioning
sessions conducted at the 2- or 10-s trace interval (two in the
pre-trained rats used in experiment 1b and four sessions in
experiment 2). After a 3-day washout period, experiment 1b
went on to test the effects of the D1 antagonist SCH23390
(0.025 or 0.05 mg/kg) also administered s.c. 15 min prior to a
further two conditioning sessions.
Experiment 3: implantation of guide cannulae into the mPFC
Rats were anesthetised using isoflurane delivered in oxygen
(induction, 4–5%;maintenance, 1–3%) and were secured in a
stereotaxic frame. The skull was exposed and bregma and
lambda were aligned horizontally. Bilateral infusion guide
cannulae (the ‘mouse’ model C235GS-5-1.2 of Plastic Ones,
Bilaney, UK) consisting of a 5-mm plastic pedestal that held
two 26-gauge metal tubes, 1.2 mm apart and projecting 5 mm
from the pedestal for the PL and 6 mm for the IL, were im-
planted through small holes drilled in the skull. The tips of the
guide cannulae were aimed 0.5 mm above the injection site in
the PL or IL sub-region of prefrontal cortex. The coordinates
for PL were 3 mm anterior, ±0.6 mm lateral from bregma and
4.0 mm ventral from the skull surface, and the coordinates for
IL were +3 mm anterior, ±0.6 mm lateral from bregma and
−5.0 mm ventral from the skull surface (based on pilot surger-
ies). Cannulae were secured to the skull with dental acrylic
and stainless steel screws. Double stylets (33 gauge; Plastic
Ones, Bilaney, UK) were inserted into the guides (with no
protrusion), and the guides were closed with a dust cap. Dur-
ing the 11-day recovery period, rats were checked daily and
habituated to the manual restraint necessary for the drug
microinfusions.
Experiment 3: microinfusion procedure
Rats were gently restrained, and 33-gauge injectors (Plastic
Ones, Bilaney, UK) were inserted into the guides. The injector
tips extended 0.5 mm below the guides into the PL or IL
mPFC, and the injector ends were connected through polyeth-
ylene tubing to 5-μl syringes mounted on a microinfusion
pump. A volume of 0.5 μl/side of 0.9 % saline or of
SKF81297 in saline was then infused bilaterally over 1 min.
The movement of an air bubble, which was included in the
tubing, was monitored to verify that the injection was success-
fully infused. The injector remained in place for one additional
minute to allow for tissue absorption of the infusion bolus.
The injectors were then removed and the stylets replaced.
The conditioning session started 10 min after the infusion.
The solution of SKF81297 used was dissolved in saline at a
concentration of 1 mg/ml. This solution was aliquoted and
kept frozen until use (in the present study, not longer than
3 weeks). On the day of infusion, an aliquot was thawed and
a part of this solution was diluted to a concentration of
0.05 μg/0.5 μl with saline. Because they were bilateral,
microinfusions were administered at a total dose of 0.1 μg in
1.0 μl SKF81297 per rat.
Design and analysis
Experiment 1a was analysed in simple mixed designs with the
between-subjects factor of trace (at two levels, 2 and 10 s) and
days (at five levels). Experiments 1b and 2 included the addi-
tional between-subjects factor of drug (in each case, at three
levels of dose). In experiment 3, there were six experimental
groups run in a 2×3 factorial design, to examine the effects of
trace (at two levels, 2 and 10 s) as a function of microinjection
condition (at three levels, vehicle, PL and IL). Initial analyses
confirmed no difference between the vehicle injections at PL
and IL coordinates so these groups were combined for all
subsequent analyses. To assess effects over the course of ac-
quisition, the repeated measures factor was days. Significant
three-way interactions were followed up by simple main
effects analyses, and further post hocs were by Fisher’s
LSD test.
The dependent variable was, in each case, the number of
nose pokes into the food magazine. To separate out effects on
motor responding or motivation for food reward, similar anal-
yses were conducted on the ITI and US response measures.
Additionally, the responding of the animals during the 10-s
trace interval between CS offset and US delivery was also
examined and tested for any effects of drug condition in ex-
periments 2 and 3. The 10-s ISI was broken down into two
second bins of time and analysed using repeated measures
ANOVAs by bins and days. In experiments 2 and 3, extinction
to the light background was examined using the same design,
in this case, in relation to six blocks of five unrein-
forced stimulus presentations (since there was only
1 day of extinction testing).
Results
The results reported below detail responding for the different
response periods of the trace conditioning task, comparing the
effects of SCH23390 and SKF81297 in experiment 1b, exam-
ining the effects of systemic SKF81297 on acquisition in ex-
periment 2 and the effects of microinfusions of SKF81297 in
PL and IL mPFC in experiment 3.
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Experiment 1a
There was a main effect of days which arose because
responding to the CS increased as conditioning progressed,
F(4,88)=27.397, p<0.001. More importantly, there was a ro-
bust effect of trace, both overall, F(1,22)=11.99, p=0.002,
and in interaction with days, F(4,88)=11.405, p<0.001.
Follow-up analyses showed significant effects of days in an-
imals conditioned at the 2-s, F(4,44)=24.08, p<0.0001, as
well as at the 10-s, F(4,44)=3.90, p<0.01, trace interval. This
means that there was evidence for an acquisition function in
both trace-conditioned groups and the interaction between
trace and days most likely arises because of a difference in
the slope of the acquisition function in relation to the trace
interval in use. The effect of trace was selective to the measure
of associative learning provided by CS responding in that
there were no such effects involving trace for responding in
the ITI, maximum F(1,22) = 1.117, p=0.302, or for
responding when food was delivered in the US period,
Fs <1 (Table 1).
Experiment 1b
Effects of SKF81297 in pre-trained animals
ANOVA of CS responding over the 2 days of treatment with
SKF81297 showed a main effect of trace, F(1,18)=17.691,
p=0.001, because responding was overall higher in the group
conditioned at 2 s. There was also an interaction between days
and drug, F(2,18)=5.335, p=0.015. Table 2 shows that
responding tended to increase on the second day under saline
and 0.4 whereas responding tended to drop under 0.8 mg/kg
SKF81297. No other effects were significant, maximum F(2,
18)=2.585, p=0.103, for the main effect of drug. ANOVA of
US responding showed no indication of any non-specific ef-
fects under SKF81297, maximum F(2,18)=1.152, p=0.338.
However, in the ITI, the main effect of days, F(1,18)=6.333,
p=0.022, was accompanied by an interaction between days
and drug, F(2,18)=3.966, p=0.037. Table 2 shows that whilst
under saline, responding was further increased in the ITI from
day 1 to day 2; under SKF81297, responding was lower and
further dropped on the second day. The main effect of drug
was marginal, F(2,18)=3.505, p=0.052.
Effects of SCH23390 in pre-trained animals
ANOVA of CS responding over the 2 days of treatment with
SCH23390 showed a main effect of days, F(1,18)=8.027, p=
0.011, a days by trace interaction, F(1,18)=27.428, p<0.001,
a days by drug interaction, F(2,18)=4.666, p=0.023, and a
main effect of drug, F(2,18)=15.775, p<0.001. Table 3 shows
that in addition to the expected difference in conditioning in
the 2- and 10-s trace groups, CS responding was very much
reduced under drug. Consistent with motor or motivational
impairment, treatment with SCH23390 also reduced
responding to collect the food US; this effect was confirmed
as a main effect of drug, F(2,18)=18.912, p<0.001, and a
drug by days interaction, F(2,18)=4.813, p=0.021, as the ef-
fect of drug was even more marked on the second day
(Table 3). Consistent with motor impairment, treatment with
SCH23390 similarly reduced responding in the ITI, F(2,18)=
18.215, p<0.001. There was also an interaction between days
and trace on responding in the ITI, F(1,18)=4.670, p=0.044.
This arose because generally lower ITI responding in rats
conditioned at the 2-s trace interval tended to drop further on
the second day of drug testing, whereas generally higher ITI
responding in rats conditioned at the 10-s trace interval tended
to further increase on the second day. No other effects or
interactions were significant, maximum F(2,18)=3.100, p=
0.070.
Experiment 2
ANOVA of CS responding showed effects of days, F(3,126)=
31.908, p<0.001, days by trace, F(3,126)=22.377, p<0.001,
days by drug, F(6,126)=2.663, p=0.018, and days by trace by
drug, F(6,126)=5.146, p<0.001. There were also significant
main effects of trace, F(1,42)=110.986, p<0.001, drug, F(2,
42)=85.493, p<0.001, and an overall trace by drug interac-
tion, F(2,42)=35.148, p<0.001. Figure 1 shows that the key
Table 1 Mean nose poke responding (±SEM) during 5-s presentations of the conditioned stimulus (CS), 5 s after food unconditioned stimulus (US)
delivery or in the inter-trial interval (ITI) (N=12/cell)
CS US ITI
Trace 2 s 10 s 2 s 10 s 2 s 10 s
Day 1 16.33 (±2.53) 15.75 (±3.47) 32.92 (±4.99) 31.25 (±4.40) 192.00 (±30.21) 156.92 (±22.18)
Day 2 36.17 (±4.91) 19.42 (±2.74) 38.08 (±4.85) 36.58 (±4.95) 179.25 (±23.96) 147.92 (±30.50)
Day 3 44.75 (±6.28) 19.25 (±3.21) 37.67 (±5.65) 33.67 (±4.16) 153.50 (±29.90) 160.25 (±40.13)
Day 4 59.67 (±9.88) 25.00 (±3.49) 40.83 (±6.36) 43.67 (±4.38) 192.75 (±46.08) 200.42 (±36.65)
Day 5 76.50 (±11.80) 28.42 (±5.22) 37.08 (±5.97) 41.50 (±5.32) 160.67 (±39.53) 168.67 (±33.06)
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three-way interaction arises because the acquisition function
seen under saline at the 2-s trace interval was depressed under
SKF81297 at both doses. Analysis confined to the 2-s trace
group also showed a significant interaction between days and
drug, F(6,63)=4.83), p<0.001. Whereas, in the saline group,
CS responding increased progressively over the 4 days of
testing, this acquisition effect was less pronounced in animals
injected with 0.4 mg/kg of the drug and totally absent after
injection of 0.8 mg/kg of SKF81297. CS responding was re-
duced under both doses of SKF81297 and stayed decreased as
compared to saline over the four consecutive days of testing
(day 1—F(2,21)=25.94, p<0.0001; saline vs 0.4 mg/kg,
p<0.0001; saline vs 0.8 mg/kg, p<0.0001; day 4—F(2,21)=
69.35, p<0.0001; saline vs 0.4 mg/kg, p<0.0001; saline vs
0.8 mg/kg, p<0.0001). Whilst analysis confined to the 10-s
trace group also showed a significant interaction between days
and drugs, F(6,63)=2.27, p=0.0478), this effect can be seen
to be due to a marginal decrease in the number of nose pokes
over days in the saline group (Fig. 1).
Systemic administration of SKF81297 also affected collec-
tion of the food US in untrained animals. ANOVA of US
responding showed in addition to the effects of days, F(3,
126)=8.288, p<0.001, and days by trace, F(3,126)=3.060,
p=0.031, interactions of drug by days, F(6,126)=2.197, p=
0.047, and drug by days by trace, F(6,126)=3.309, p=0.005.
There was also a significant main effect of drug, F(2,42)=
19.684, p<0.001, as well as an overall trace by drug interac-
tion, F(2,42)=6.160, p=0.005. Analysis confined to the 2-s
trace group showed a significant interaction between days and
drug, F(6,63)=5.43, p<0.0001. This interaction can be seen to
be due to a reduction in US responding in the saline group
over the 4 days of testing which was not seen in drug-treated
animals. Follow-up analyses confirmed that the difference in
US responding between the saline and 0.8 mg/kg SKF81297
2-s trace-conditioned groups seen on day 1 and day 2 was no
longer significant by day 3 of testing (day 1—F(2,21)=13.87,
p<0.0001; saline vs 0.8 mg/kg, p<0.0001; day 2—F(2,21)=
22.63, p<0.0001; saline vs 0.8 mg/kg, p<0.0001; day 3—
F(2,21)=3.27, p=0.06). Analysis confined to the 10-s trace
group showed a main effect of drug, F(2,21)=14.64,
p<0.0001, but no interaction between drug and days, F(6,
63)=1.00, p=0.43. Inspection of Fig. 1 shows that US
Table 2 Mean nose poke responding (±SEM) during 5-s presentations of the conditioned stimulus (CS), 5 s after food unconditioned stimulus (US)
delivery or in the inter-trial interval (ITI) after treatment with SKF (0.4 or 0.8 mg/kg) (N=4/cell)
Trace 2 s 10 s
SKF Saline 0.4 mg/kg 0.8 mg/kg Saline 0.4 mg/kg 0.8 mg/kg
CS
Day 1 63.50 (±15.46) 66.750 (±20.70) 43.75 (±11.43) 28.50 (±7.05) 15.75 (±4.50) 16.00 (±4.67)
Day 2 74.50 (±16.04) 76.00 (±18.22) 31.00 (±3.81) 34.00 (±11.02) 16.25 (±6.80) 9.75 (±1.55)
US
Day 1 29.25 (±11.61) 28.75 (±7.57) 26.00 (±2.80) 30.25 (±0.48) 38.50 (±5.56) 32.25 (±1.80)
Day 2 34.75 (±13.03) 28.50 (±2.33) 21.75 (±1.31) 25.75 (±4.01) 37.00 (±4.02) 29.25 (±2.75)
ITI
Day 1 323.75 (±144.09) 168.00 (±55.02) 133.50 (±12.33) 182.75 (±36.25) 95.25 (±34.11) 144.00 (±47.84)
Day 2 319.75 (±154.97) 99.75 (±32.80) 48.50 (±11.57) 221.75 (±68.07) 71.50 (±33.93) 77.50 (±16.09)
Table 3 Mean nose poke responding (±SEM) during 5-s presentations of the conditioned stimulus (CS), 5 s after food unconditioned stimulus (US)
delivery or in the inter-trial interval (ITI) after treatment with SCH (0.25 or 0.5 mg/kg) (N=4/cell)
Trace 2 s 10 s
SCH Saline 0.025 mg/kg 0.05 mg/kg Saline 0.025 mg/kg 0.05 mg/kg
CS
Day 1 67.75 (±24.73) 17.00 (±2.12) 6.50 (±1.94) 35.00 (±5.45) 0.75 (±0.25) 0.25 (±0.25)
Day 2 62.75 (±22.16) 4.75 (±2.59) 0.25 (±0.25) 42.00 (±6.79) 0.50 (±0.29) 0.50 (±0.29)
US
Day 1 28.00 (±6.87) 21.25 (±5.31) 14.25 (±2.06) 29.00 (±1.83) 23.75 (±2.78) 9.75 (±3.77)
Day 2 27.25 (±4.48) 11.00 (±5.58) 1.75 (±0.85) 26.25 (±2.75) 9.50 (±2.47) 2.75 (±0.85)
ITI
Day 1 126.25 (±49.72) 36.50 (±13.18) 14.25 (±2.66) 175.75 (±48.32) 21.50 (±5.11) 7.00 (±2.12)
Day 2 100.50 (±26.52) 32.50 (±13.74) 9.00 (±6.14) 209.75 (±50.61) 15.75 (±2.25) 12.75 (±3.40)
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responding was overall highest in the 10-s saline group and
the level of US responding seen under 0.8 mg/kg was low.
Thus, saline-treated animals actively seek the food even
though they have been poorly conditioned to the tone at the
10-s trace interval, but under 0.8 mg/kg SKF81297, the incen-
tive to nose poke was reduced.
ANOVA of responding in the ITI showed an interaction
between days and trace, F(3,126)=3.370, p=0.021, a main
effect of trace, F(1,42)=8.463, p=0.006, and, in this case, just
a main effect of drug, F(2,42)=12.692, p<0.001. However,
this change cannot account for drug effects on CS and US
responding which were different by trace interval. Figure 1
shows the 5-s pre-CS portion of the ITI for direct comparison
with the responding in the 5 s of CS presentation and 5 s after
US delivery.
There was no evidence for any selective effect of drug, on
the distribution of responding within the 10-s trace interval,
maximum F(1,21)=1.908, p=0.182, for the effect of bins in
the linear trend.
Other than an interaction between blocks and drug in the
linear trend F(2,42)=3.709, p=0.033, there were no signifi-
cant effects for responding to the light background stimulus
(and response rates were very low).
Experiment 3
Histology
Three rats were excluded on histological grounds. One further
rat was excluded because an injection cannula was blocked.
This left a final sample size of 37 (n=5–8/cell). Two
rats had placements on the borderline of PL and IL, but
their exclusion made no difference to the results (see
below). As shown in Fig. 2a, there was no evidence
of gliosis at the cannula tip. Figure 2b illustrates the
full range of cannula placements.
Behaviour
Statistical analysis confirmed that within the saline-injected
group, the PL or IL site of the injection made no difference
to the acquisition function at the different trace intervals, max-
imum F(3,27)=1.614, p=0.209, for days by trace by injection
coordinates. Therefore, animals injected with saline in either
PL or IL were combined to form a single control group, com-
pared with SKF81297 injections at these coordinates using the
Fig. 1 Mean nose pokes are shown as a function of the 4 days of
conditioning (D1 to D4) for the 5 s of the inter-trial interval (ITI) just
prior to conditioned stimulus (CS) presentation (Pre-CS) as compared
with during the 5-s CS presentation or in the 5-s post-CS when food
was delivered (US). Diamonds denote rats conditioned at the 10-s trace
interval, and circles denote rats conditioned at the 2-s trace interval after
treatment with SKF81297 (s.c.) at 0.8 mg/kg (black fill) or 0.4 mg/kg
(grey fill) in experiment 2. Control rats (white fill) were injected with
saline
Fig. 2 a Photograph of a representative placement which illustrates the
area around the injection. There is no obvious indication of gliosis as a
result of the microinfusions. bApproximate locations of infusion cannula
tips, in the prelimbic (black dots) and infralimbic (grey dots) sub-regions
of the mPFC. The placements on the borderline with the prelimbic area
but which were not clearly infralimbic are also shown in black. Place-
ments are shown on coronal plates adapted from Paxinos and Watson
(1998), with numbers indicating distance from bregma in millimetres
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factor of infusion (at three levels: saline; SKF81297 in PL;
SKF81297 in IL).
As would be expected, responding to the CS increased over
the 4 days of testing and there was a clear main effect of days,
F(3,93)=24.676, p<0.001. The days by trace interaction was
also significant, F(3,93)=18.076, p<0.001, because the
increase responding was overall greater in the 2-s than
in the 10-s trace-conditioned group. The three-way in-
teraction with infusion was significant in the linear
trend, F(2,31)=3.399, p=0.046. Figure 3 shows that
the acquisition function at the 2-s trace interval was less
steep in rats infused with SKF81297 in either the PL or
IL sub-region, compared with the saline-infused control
group. In line with this lack of difference in relation to
mPFC sub-region, excluding the two PL/IL borderline
cases made no difference to the interaction, F(2,29)=
3.582, p=0.041. Follow-up analysis of the 2-s trace
showed that the interaction between days and infusion
approached significance, F(6,54)=2.096, p=0.069, while
this interaction did not approach significance for the
equivalent analysis of the 10-s trace group, F(6,39)=
0.53, p=0.77. Together, these analyses suggest that an-
imals infused with SKF81297 into the mPFC reduced
learning and the difference by trace identified by the
three-way interaction arose because this difference was
most apparent in animals conditioned at the 2-s trace
interval. Day-by-day analyses of CS responding con-
firmed that main effects of infusion developed by day
3, F(2,18)=6.431, p=0.007, and day 4, F(2,18)=3.680,
p=0.0457. On day 3, the main effect of infusion was
due to a difference between saline and PL groups (sa-
line vs PL, p=0.002; saline vs IL, p=0.094), whilst by
day 4, both IL- and PL-infused animals nose poked less
than controls (saline vs PL, p=0.035; saline vs IL, p=
0.026). There was no such effect of infusion on day 1,
F(2,18)=0.16, p=0.85, or day 2, F(2,18)=0.61, p=0.55.
Thus, infusion effects became apparent over the course
of acquisition at the 2-s trace interval. This pattern of
results, whereby rats injected with SKF81297 did not
reach the same high levels of responding seen in the
saline 2-s trace-conditioned group, could be consistent
with a motor or motivational effect of SKF81297 infu-
sions which might result in an effective ceiling in
responding.
There was a main effect of days on overall ITI responding,
F(3,93)=3.734, p=0.014, but there was no indication of any
general motor effect of SKF81297 infusions in that there were
no significant effects involving infusion on responding in the
ITI, maximum F(2,31)=1.095, p=0.347, for the main effect
of infusion. Similarly, there was nothing to suggest motiva-
tional impairment in that there were no significant effects in-
volving infusion in the US period when food was delivered,
maximum F(2,31)=1.045, p=0.364, for infusion by days in
the linear trend. We therefore conclude that SKF81297
in PL or IL mPFC attenuated conditioning over a short
2-s trace interval.
Responding distributed within the 10-s trace interval
in that there was a main effect of the 2-s time bins, F(4,
156)=3.272, p=0.018. However, there was no evidence
for any modulation of timing by DA D1 activation in
mPFC in that there was no effect of infusion on the
distribution of responding within the 10-s trace interval,
all Fs <1. Finally, there were no significant effects in
the analyses of responding to the light background stim-
ulus, maximum F(1,31)=2.959, p=0.095, for the main
effect of blocks in the linear trend.
Fig. 3 Mean nose pokes are shown as a function of the 4 days of
conditioning (D1 to D4) for the 5 s of the inter-trial interval (ITI) just
prior to conditioned stimulus (CS) presentation (Pre-CS) as compared
with during the 5-s CS presentation or in the 5-s post-CS when food
was delivered (US). Diamonds denote rats conditioned at the 10-s trace
interval, and circles denote rats conditioned at the 2-s trace interval after
infusion of SKF81297 into infralimbic (IL, black fill) or prelimbic (PL,
grey fill) regions of medial prefrontal cortex (mPFC) in experiment 3.
Control rats (white fill) were injected with saline
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Discussion
Experiment la showed rapid acquisition of associative learn-
ing at 30 trials per day. As expected, there was a clear acqui-
sition function for rats conditioned at a 2-s, as compared with
at a 10-s trace interval. Experiment lb showed that whilst the
administration of SCH23390 resulted in a number of non-
specific effects, consistent with impaired motor responding
and/or motivation, systemic administration of SKF81297
had relatively little effect in pre-trained animals. Therefore,
experiment 2 went on to test the effects of systemically ad-
ministered SKF81297 on the acquisition of trace conditioning.
It was found that systemic SKF81297 depressed acquisition at
the 2-s trace interval which was suitable to detect any trace
conditioning impairment. The fact that there was no further
decrease in conditioning at the 10-s trace interval can be at-
tributed to a floor effect (the 10-s interval was included to test
for trace conditioning enhancement). There were a number of
non-specific effects, but these did not match the profile of
effects on trace conditioning (which depended on the trace
interval in use). In experiment 3, SKF81297 (0.1 μg in
1.0 μl) administered directly in PL and IL sub-regions of
mPFC similarly impaired appetitive conditioning conducted
at the 2-s trace interval. However, this effect was less marked
than that seen after systemic administration in experiment 2.
There was no evidence within the present study for functional
differentiation between PL and IL mPFC in that the same
effect was seen, irrespective of injection coordinates.
Why was trace conditioning impaired rather than enhanced?
There is good evidence that DA D1 activation within mPFC
plays an important role in working memory (Arnsten et al.
1994; Cai and Arnsten 1997). The reduction in trace condi-
tioning under SKF81297 observed in the present study stands
in apparent contrast to the evidence that DA D1 agonists can
restore cognitive function which has been impaired, for exam-
ple in relation to age or in consequence of neuropathology
(Deutch 1993; Dolan et al. 1994; Mizoguchi et al. 2002).
Trace conditioning clearly relies on attentional as well work-
ing memory processes (Han et al. 2003; Gilmartin et al. 2014).
However, SKF81297 administered systemically or by infu-
sion directly into mPFC similarly improves attentional perfor-
mance measured in the serial reaction time task (Granon et al.
2000). We were unable to demonstrate improved cognitive
function in the present study, and this despite the inclusion
of a longer trace interval, which should have been suitable to
detect cognitive enhancement in that this is most readily dem-
onstrated in cases of low behavioural baseline performance
(Granon et al. 2000). Low baseline performance may also
occur in consequence of underlying pathology, for example
due to ageing (Cai and Arnsten 1997) or due to DA neurode-
generation in Parkinson’s disease (Lange et al. 1992).
This apparent conflict between the results of the present
study and previously published findings can be explained in
relation to the need to maintain DA within the appropriate
physiological range for optimal cognitive function. In partic-
ular, there is good evidence to suggest that D1 activity in
mPFC follows an inverted U-function. In other words, both
hypo- and hyper-activation of these receptors can result in
impairments (Arnsten et al. 1994; Arnsten 1998; Cai and
Arnsten 1997; Pezze et al. 2014; Zahrt et al. 1997). For exam-
ple, in normal animals, infusion of SKF81297 into the PL/IL
regions of mPFC impaired spatial working memory; this ef-
fect was reversible by treatment with SCH23390 and was
attributed to supranormal D1 receptor stimulation (Zahrt
et al. 1997). Similarly, pretreatment with SCH23390 restored
spatial working memory which had been impaired by the
anxiogenic FG7142 (Murphy et al. 1996). Thus, whilst DA
D1 mPFC-D1 receptor activation clearly modulates working
memory, the direction of effects produced by the administra-
tion of agonists or antagonists depends on the baseline level of
activity and, in particular, whether this is lower or higher than
the physiological optimum.
Were the experimental parameters appropriate?
It is possible that the trace intervals selected for use in the
present study were not appropriate to detect the predicted en-
hancement under SKF81297. In particular, the relatively low
levels of learning seen in the rats conditioned at the 10-s trace
interval might suggest that this trace interval was too long.
However, the point of examining conditioning at the 10-s trace
interval was to test for enhanced associative learning under
conditions resulting in weak associative learning in untreated
controls. Enhanced conditioning over longer trace intervals
has been observed after treatment with DA agonists albeit in
aversive rather than appetitively motivated procedures of the
kind used in the present study (Horsley and Cassaday 2007;
Norman and Cassaday 2003). The 2-s interval intended to
detect impaired trace conditioning was suitable in that such
impairment was clearly demonstrated under SKF81297 in ex-
periments 2 and 3.
The length of the ITI relative to the trace interval has been
shown to be an important variable for appetitive trace condi-
tioning and, moreover, a determinant of its sensitivity to hip-
pocampal lesion effects (Chan et al. 2014). In the present
study, the ITI was variable and relatively short (at least 1.5
times longer than the ISI length). However, effects of
SKF81297 were nonetheless demonstrated.
Another possible limitation arises in that the prolonged
conditioning sessions needed to train the animals over fewer
days (so that the microinjection study would be viable) may
have exceeded the period for which SKF81297 was sufficient-
ly effective. However, this is unlikely to have been a problem
in that the effects of D1 agonists have been documented to be
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maintained for 30 min or more (Mizoguchi et al. 2002; Sorg
et al. 2001; Zahrt et al. 1997). Thus, although the half-life of
SKF81297 is unclear, based on these previous studies, it is
likely to exceed 30 min. Therefore, the treatments used in
the present study are likely to retain some effectiveness up to
60 min, albeit this may have been reduced in the latter portion
of the session.
Would the same results be expected in aversively motivated
procedures?
Aversive trace conditioning has been more extensively stud-
ied, particularly in relation to the role of hippocampus in trace
but not delay conditioning (Solomon et al. 1986; Moyer et al.
1990; Gabrieli et al. 1995; Weitemier and Ryabinin 2004;
Misane et al. 2005), but with appropriate training parameters,
a role for hippocampus in appetitive trace conditioning can
also be demonstrated (Chan et al. 2014). Whilst a microdial-
ysis study has shown that ACh release, in both mPFC and
hippocampus, was greater during appetitive trace conditioning
than during delay conditioning (Flesher et al. 2011), to our
knowledge, there has been little previous work on the role of
mPFC in appetitive trace conditioning.
Dopaminergic mechanisms are clearly involved in both
appetitive (Dalley et al. 2002) and aversive conditioning
(Feenstra et al. 2001). However, comparing across appetitive
and aversive trace conditioning variants, there is some evi-
dence for differences in the underlying mechanisms. For ex-
ample, when the effects of electrolytic lesions to nucleus ac-
cumbens were compared in appetitive and aversively motivat-
ed procedures, effects on trace conditioning were found to
depend on whether the procedure in use was aversively or
appetitively motivated (Cassaday et al. 2005). DA agonists
such as amphetamine and methylphenidate enhanced aversive
trace conditioning (Horsley and Cassaday 2007; Norman and
Cassaday 2003). However, in an appetitive procedure, the
same as that used here apart from being conducted at fewer
trials per day over an increased number of days, associative
learning was enhanced only in a 0-s (delay) conditioned group
and then only when CS responding was corrected for the
generally depressed responding seen under these compounds
in the ITI (Cassaday et al. 2008). The predicted increase in
conditioning to the trace CS was not seen using a similar
appetitive trace conditioning procedure (Cassaday et al.
2008; Kantini et al. 2004).
Conclusions
Experiment 3 identified a role for DA D1 receptors in PL and
IL mPFC sub-regions. However, the effects of SKF81297
microinfusion in mPFC were modest compared with those
seen after systemic injection. In part, this difference may
reflect reduced non-specific effects with more localised ad-
ministration to mPFC sub-regions. In any case, the profile of
motor and motivational changes after treatment with systemic
SKF81297 did not match that seen on CS responding. Thus
the mismatch between the effects of SKF81297 administered
systemically versus directly into mPFC suggests that whilst
there is evidence that DA D1 receptors in mPFC modulate
trace conditioning, the effects of DA D1 agents are unlikely
to be mediated only within the IL and PL mPFC sub-regions
examined in the present study. Comparison of the results of
experiments 2 and 3 suggests that DA Dl receptors outside of
mPFC are also important to trace conditioning.
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